Silexion Therapeutics Corp - Ordinary shares, par value $0.135 per share (SLXNW)

Q: What does CUSIP G1281K114 represent in this 13F holders report?

CUSIP G1281K114 is the security identifier for SLXNW - Silexion Therapeutics Corp - Ordinary shares, par value $0.135 per share used to aggregate holder disclosures.

Q: How many institutions held SLXNW - Silexion Therapeutics Corp - Ordinary shares, par value $0.135 per share in Q3 2024?

27 institutional investors reported SLXNW - Silexion Therapeutics Corp - Ordinary shares, par value $0.135 per share for Q3 2024. Use the holders table for investor-level position and value details.

CUSIP: G1281K114

Q3 2024 13F Holders as of 30 Sep 2024

Security type / class: Equity / Ordinary shares, par value $0.135 per share
Total 13F shares: 2,088,527
Total 13F value: $66,997
Share change: +2,088,527
SEC-reported price per share: $0.03
Number of holders: 27
Value change: +$66,997
Number of buys: 27

Security key

G1281K114

Report period

Q3 2024

Institutions

Top holders

SLXNW full security history Ownership snapshot Full 13F holder table Silexion Therapeutics Corp SEC filings Silexion Therapeutics Corp company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of SLXNW - Silexion Therapeutics Corp - Ordinary shares, par value $0.135 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Wildcat Capital Managemen...

Disclosed value leader

—

Comparable rows

0/2

Latest evidence

15 Aug 2024

3/4/5 Some rows are evidence-backed but not safely comparable across classes. 2 rows are not safely comparable across share classes.

Quick read

SEC ownership evidence is available, but the rows are not safely comparable across share classes.

0 of 2 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Wildcat Capital Management, LLC's linked filing trail.

Detailed SEC evidence table Showing 1-2 of 2 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Wildcat Capital Management, LLC	3/4/5 10%+ Owner 3/4/5	— class O/S missing	— 1,020,852 shares	—	15 Aug 2024
Ilan Shiloah	3/4/5 Director 3/4/5	— class O/S missing	— 387,883 shares	—	15 Aug 2024

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

2,088,527

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders

Q3 2024 holders

Holder diff

Investor	Q2 2024 Shares	Q3 2024 Shares	Share Diff	Share Chg %	Q2 2024 value	Q3 2024 value	Value change	Value Chg %